Çavdarlı, B. Et Al. 2023. High diagnostic yield of targeted next-generation sequencing panel as a first-tier molecular test for the patients with myopathy or muscular dystrophy.. Annals of human genetics , vol.87, no.3 , 104-114.

Çavdarlı, B., Köken, Ö., Satılmış, S. B. A., Bilen, Ş., Ardıçlı, D., Ceylan, A. C., ... Gündüz, C. N. S.(2023). High diagnostic yield of targeted next-generation sequencing panel as a first-tier molecular test for the patients with myopathy or muscular dystrophy.. Annals of human genetics , vol.87, no.3, 104-114.

Çavdarlı, Büşranur Et Al. "High diagnostic yield of targeted next-generation sequencing panel as a first-tier molecular test for the patients with myopathy or muscular dystrophy.," Annals of human genetics , vol.87, no.3, 104-114, 2023

Çavdarlı, Büşranur Et Al. "High diagnostic yield of targeted next-generation sequencing panel as a first-tier molecular test for the patients with myopathy or muscular dystrophy.." Annals of human genetics , vol.87, no.3, pp.104-114, 2023

Çavdarlı, B. Et Al. (2023) . "High diagnostic yield of targeted next-generation sequencing panel as a first-tier molecular test for the patients with myopathy or muscular dystrophy.." Annals of human genetics , vol.87, no.3, pp.104-114.

@article{article, author={Büşranur Çavdarlı Et Al. }, title={High diagnostic yield of targeted next-generation sequencing panel as a first-tier molecular test for the patients with myopathy or muscular dystrophy.}, journal={Annals of human genetics}, year=2023, pages={104-114} }